Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
NeoImmuneTech
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
Boston Scientific Corporation
University of California, San Diego
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pheon Therapeutics
Boehringer Ingelheim
Pheon Therapeutics
Auricula Biosciences Inc.
DualityBio Inc.
Swansea Bay University Health Board
Inhibrx Biosciences, Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exelixis
Tanabe Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CRISPR Therapeutics
Yonsei University
Yonsei University
Seattle Children's Hospital
Seattle Children's Hospital
Centre Hospitalier Universitaire de Nīmes
Massive Bio, Inc.
St. Jude Children's Research Hospital
SillaJen, Inc.
Thomas Jefferson University
Sichuan Baili Pharmaceutical Co., Ltd.
The First Affiliated Hospital of Zhengzhou University
Travera Inc
Weill Medical College of Cornell University
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Numab Therapeutics AG
West China Hospital
Laval University
Laval University
HiberCell, Inc.
Stanford University
Sichuan University
Boston Scientific Corporation